Search

Now showing items 1-10 of 13

Cost-effectiveness of Population Screening for BRCA Mutations in Ashkenazi Jewish Women Compared With Family History-Based Testing

Manchanda, R; Legood, R; Burnell, M; McGuire, A; Raikou, M; Loggenberg, K; Wardle, J; Sanderson, S; Gessler, S; Side, L;... (2015-01)

Current detection rates and time-to-detection of all identifiable BRCA carriers in the Greater London population

Manchanda, R; Blyuss, O; Gaba, F; Gordeev, VS; Jacobs, C; Burnell, M; Gan, C; Taylor, R; Turnbull, C; Legood, R;... (2018-08)

Cost effectiveness of population based BRCA1 founder mutation testing in Sephardi Jewish women

Patel, S; Legood, R; Evans, DG; Turnbull, C; Antoniou, AC; Menon, U; Jacobs, I; Manchanda, R (2018-04)

Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1/2 mutations

Manchanda, R; Burnell, M; Loggenberg, K; Desai, R; Wardle, J; Sanderson, SC; Gessler, S; Side, L; Balogun, N; Kumar, A;... (2016-07)

Defining the risk threshold for risk reducing salpingo-oophorectomy for ovarian cancer prevention in low risk postmenopausal women.

Manchanda, R; Legood, R; Pearce, L; Menon, U (2015-12)

OBJECTIVE: To define risk thresholds for cost-effectiveness of risk-reducing salpingo-oophorectomy (RRSO) for ovarian cancer (OC) prevention in low/intermediate risk postmenopausal women. METHODS: A decision-analytic model ...

Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women

Manchanda, R; Patel, S; Gordeev, VS; Antoniou, AC; Smith, S; Lee, A; Hopper, JL; MacInnis, RJ; Turnbull, C; Ramus, SJ;... (2018-07)

Specifying the ovarian cancer risk threshold of "premenopausal risk-reducing salpingo-oophorectomy' for ovarian cancer prevention: a cost-effectiveness analysis

Manchanda, R; Legood, R; Antoniou, AC; Gordeev, VS; Menon, U (2016-09)

Search

Cost-effectiveness of Population Screening for BRCA Mutations in Ashkenazi Jewish Women Compared With Family History-Based Testing

Current detection rates and time-to-detection of all identifiable BRCA carriers in the Greater London population

Cost effectiveness of population based BRCA1 founder mutation testing in Sephardi Jewish women

Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1/2 mutations

Defining the risk threshold for risk reducing salpingo-oophorectomy for ovarian cancer prevention in low risk postmenopausal women.

Randomised trial of population-based BRCA testing in Ashkenazi Jews: long-term outcomes

Commentary on changing the risk threshold for surgical prevention of ovarian cancer.

Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry

Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women

Specifying the ovarian cancer risk threshold of "premenopausal risk-reducing salpingo-oophorectomy' for ovarian cancer prevention: a cost-effectiveness analysis

Search

Filters

Cost-effectiveness of Population Screening for BRCA Mutations in Ashkenazi Jewish Women Compared With Family History-Based Testing

Current detection rates and time-to-detection of all identifiable BRCA carriers in the Greater London population

Cost effectiveness of population based BRCA1 founder mutation testing in Sephardi Jewish women

Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1/2 mutations

Defining the risk threshold for risk reducing salpingo-oophorectomy for ovarian cancer prevention in low risk postmenopausal women.

Randomised trial of population-based BRCA testing in Ashkenazi Jews: long-term outcomes

Commentary on changing the risk threshold for surgical prevention of ovarian cancer.

Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry

Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women

Specifying the ovarian cancer risk threshold of "premenopausal risk-reducing salpingo-oophorectomy' for ovarian cancer prevention: a cost-effectiveness analysis